BioCryst Pharmaceuticals, Inc. Current Part of Debt

Current Part of Debt of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Current Part of Debt growth rates and interactive chart. Current debt or short-term debt are a firm's financial obligations that are expected to be paid off within a year. It also includes the portion of long-term debt that is due within a year. It is a part of the overall indebtedness of a company, and is included in Debt/Equity and Debt/Assets ratios.

Highlights and Quick Summary

  • Current Part of Debt for the quarter ending September 30, 2022 was $2.2 Million (a 2.91% increase compared to previous quarter)
  • Year-over-year quarterly Current Part of Debt increased by 20.73%
  • Annual Current Part of Debt for 2021 was $1.82 Million (a -94.17% decrease from previous year)
  • Annual Current Part of Debt for 2020 was $31.2 Million (a 245.67% increase from previous year)
  • Annual Current Part of Debt for 2019 was $9.02 Million (a 96.94% increase from previous year)
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Current Part of Debt of BioCryst Pharmaceuticals, Inc.

Most recent Current Part of Debtof BCRX including historical data for past 10 years.

Interactive Chart of Current Part of Debt of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. Current Part of Debt for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $2.2 $2.13 $2.08 –
2021 $1.82 $31.45 $30.98 $31.0 $1.82
2020 $31.18 $19.15 $19.06 $14.03 $31.18
2019 – – $9.02 $4.04 $9.02
2018 $4.58 $1.62 $6.53 $6.5 $4.58
2017 $6.46 $4.73 $3.0 $1.28 $6.46
2016 – – – – $28.24

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com